Loading decisions…
Loading decisions…
16,110 vetted Board decisions for Prostate cancer.
The Veteran's TDIU and DEA benefits are granted as of August 1, 2022. However, the Veteran's claim for an increased rating for prostate cancer is denied.
The Veteran's claim for service connection for prostate cancer was granted with an effective date of September 1, 2023. The decision is based on new evidence submitted after a previous denial.
The Veteran's claims for service connection are being remanded due to the need for further development regarding his alleged toxic exposure during service.
The Board has determined that the service connection for prostate cancer should be remanded due to conflicting information regarding the Veteran's service on USS Ticonderoga and his exposure to herbicides. The case will be reviewed with an updated medical opinion considering all relevant evidence.
The appeal of a proposed reduction from 100 percent to 60 percent for prostate cancer, status post prostatectomy with voiding dysfunction, is dismissed as a matter of law.
The Veteran's claim for an initial compensable rating for residuals of prostate cancer was denied as his prostate cancer did not result in voiding dysfunction and/or renal dysfunction.
The Veteran's heart disease, prostate cancer, and bone cancer secondary to prostate cancer have been granted effective dates of October 26, 2021, November 17, 2021, and November 17, 2021, respectively.,A higher level of special monthly compensation (SMC) is remanded.
The Board has granted service connection for prostate cancer and erectile dysfunction, secondary to prostate cancer. The claim of service connection for a psychiatric disability is denied as new and relevant evidence was not received.
The Board denied service connection for prostate cancer and the temporary total evaluation due to treatment requiring convalescence as there was no evidence linking the condition to service, including exposure to herbicides or other toxins.
The Veteran's residuals of prostate cancer are rated at the maximum schedular disability rating (60%) and no higher due to his use of an appliance.,The Veteran's type II diabetes mellitus with erectile dysfunction is not entitled to a higher than 20% rating as he does not require insulin or regulation of activities.
The Board has granted a disability rating of 20 percent for the Veteran's residuals of prostate cancer, effective January 1, 2021. The rating is subject to controlling regulations governing the payment of monetary awards.
The Veteran's prostate cancer with voiding dysfunction is granted on a basis other than the PACT Act, and his erectile dysfunction as secondary to this condition is also granted. The effective dates for these determinations are not specified.
The Board has denied the Veteran's claims for service connection for a lumbar spine disability, glaucoma, sleep apnea, and prostate cancer residuals. The claim for headaches (migraines) is being remanded.,There was no current diagnosis of a lumbar spine disability at any relevant time during the pendency of the claim or recent to the filing of the claim.
The Board has remanded the case due to a lack of adequate medical opinion regarding the etiology of the appellant's prostate and liver cancer, which is believed to be related to his military service at Camp Lejeune.
The Board has denied the Veteran's claim of entitlement to service connection for prostate cancer, but a remand is required due to an error in notifying him of his right to a hearing.
The Veteran's prostate cancer is found to be related to his active service, and service connection for this condition is granted.
The Veteran's tinnitus had onset in service and has persisted since then. The Board granted service connection for this condition.
The Board has remanded the claims for service connection due to a failure to schedule the Veteran for a VA examination and to obtain SSA records. The claims will be reconsidered with these additional pieces of evidence.
The Veteran's claims for an increased rating for bilateral pes planus, service connection for prostate cancer, and hypertension have been denied. The Veteran was granted service connection for bilateral pes planus at a 30 percent evaluation effective August 14, 2023.
The Veteran's heart condition, rated at 100 percent since July 18, 2023, and his prostate cancer, also rated at 100 percent since January 16, 2020, meet the criteria for SMC Housebound effective July 18, 2023.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.